About BCSI


Blood Cell Storage, Inc. (BCSI) is an international medical device company based in Seattle, Washington, with European operations located in The Netherlands.

BCSI has created two unique product lines that benefit patients, clinicians, researchers, pathologists and doctors using patented technologies. Our fluorescent dyes, micro-fluidics, Nucleic Acid Extraction capabilities and automated systems reduce healthcare costs while improving patient outcomes.



SAFE Family of Products

SAFE Sens

The SAFE Sens (Sterile, Automated Fluoroscopic Evaluation) IVM (In Vessel Monitor) is an optical fluorescent measurement device. It is used in combination with a disposable sensor, to accurately and reliably measuring the pH of small volumes of fluids such as the media used in IVF. The sensor contains a proprietary fluorescent dye that is pH sensitive. Each lot of sterile sensors last 6 days and are pre-calibrated by the manufacturer. An ID code is used to tell the SAFE Sens IVM how to specifically interpret the fluorescent measurement for each lot of sensors into a pH value.

SAFE Sens

Watch Video »

more


pH Sterile, Automated Fluoroscopic Evaluation (SAFE)

pH SAFE from BCSI is a non-invasive system for platelets. The pH SAFE products are unique in that they enable a simple pH measurement to assess the quality of all platelet units and do not violate the sterility of the platelet storage bag, a critical limitation of current products. They can be used anywhere along the blood collection/distribution chain.

BCSI pH SAFE

The photo is of BCSI’s pH SAFE System, the world's first non-invasive monitoring system for platelets.

Watch Video »

more

SNAP Family of Products

BCSI Simple Nucleic Acid Processing (SNAP)

DNA Card

Pure Nucleic Acids, Hassle Free™

BCSI’s Simple Nucleic Acid Processing (SNAP) family of products is built around our proprietary flat glass extraction technology. Capable of quickly, easily, and reliably isolating nucleic acids (DNA and RNA) from blood and a variety of other biological specimens, SNAP can help improve extraction in your lab.

Watch Video »

more


Latest News

10.14.2013  BCSI Announces Efforts to Use pH Monitoring to Identify Compromised Platelet Products

DENVER, CO – October 14, 2013 – Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the annual AABB meeting in Denver, Colorado, that they are exploring the viability of using the pH SAFE® products with regular pH readings to identify compromised platelet products.  Laboratory studies are underway whereby multiple daily pH measurements are being collected and where significant changes are being assessed in correlation with bacterial contamination.

10.14.2013  BCSI Announces Americas Launch of SAFE Sens IVM at ASRM; Novel New Approach to Monitor pH in Closed Incubator for In Vitro Fertilization (IVF)

BOSTON, MA – October 14, 2013 – Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the American Society for Reproductive Medicine (ASRM) annual event in Boston, that their newest product, SAFE Sens IVM (in vessel monitoring), has begun shipping to customers and is generally available. SAFE Sens IVM, is a pH monitoring system used by embryologists and clinical staff, that reports, trends and archives pH measurements without disturbing culture conditions within a closed incubator.

07.08.2013  BCSI and Planer Announce Partnership to Address Shortcomings of Current pH Monitoring Processes in Medical Clinics and Labs

LONDON, UK – BCSI, a leading medical device provider and Planer PLC, specialists in controlled temperature environments for medical labs and clinics, announced a partnership today during the annual meeting of European Society of Human Reproduction and Embryology (ESHRE). The two companies will collaborate on bringing new technologies to market to address current issues in pH monitoring for Invitro Fertilizaton (IVF) and other uses.

07.08.2013  BCSI and tech²ART Announce Partnership to Address Shortcomings of Current pH Monitoring Processes in Medical Clinics and Labs

LONDON, UK – BCSI, a leading medical device provider and tech²ART, specialists in Assisted Reproduction Technology (ART), announced a partnership today during the annual meeting of European Society of Human Reproduction and Embryology (ESHRE). The two companies will collaborate on bringing new technologies to market to address current issues in pH monitoring for Invitro Fertilizaton (IVF) and other uses.